Biotech Values

[drbio45]

Agreed. Hard to believe worldwide insulin sales will more than double in only four years even with very high growth in emerging markets.

do you mean a doubling isn't enough. If one of the attributes of this process is reducing the cost of production wouldn't that make it the insulin of choice in India and China